Cencora bolsters specialty business with $4.6 bln deal for Retina Consultants of America
Adds details on deal throughout, earnings details in paragraphs 8-11, analyst comment in paragraph 5
Nov 6 (Reuters) -Cencora COR.N will buy Retina Consultants of America from private-equity firm Webster Equity Partners for $4.6 billion, the drug distributor said on Wednesday, beefing up its presence in the market for specialty medicines.
Higher margins and growing U.S. demand for medicines that treat complex conditions such as rheumatoid arthritis and cancer have encouraged Cencora and peers Cardinal Health CAH.N and McKesson MCK.N to double down on the business.
The RCA deal will add nearly 300 retina specialists to Cencora's portfolio of physician management services. It follows the firm picking up a minority stake in OneOncology last year for around $685 million to access a network of cancer specialists.
RCA's network consists of specialists focusing on diseases including macular degeneration and diabetic retinopathy.
"The deal makes sense strategically and financially," Leerink Partners analyst Michael Cherny wrote.
Cencora, formerly known as AmerisourceBergen, would pay potential milestone payments of up to $500 million in aggregate contingent consideration in fiscal years 2027 and 2028.
Southlake, Texas-based RCA, formed by Webster Equity Partners in 2020, provides physician management and financial services to retina specialty practices under its ambit.
Separately, Cencora forecast 2025 profit above Wall Street expectations after beating fourth-quarter estimates on strength in its U.S. business.
The company projected adjusted annual profit per share in the range of $14.80 to $15.10. Analysts on average were expecting $14.71 per share, according to estimates compiled by LSEG.
Cencora in September said it expects 2025 adjusted profit to be at the lower end of its long-term forecast range of 8% to 12% growth.
On an adjusted basis, the company earned $3.34 per share in the quarter ended Sept. 30, beating estimates of $3.22.
Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar and Sriraj Kalluvila
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
